Mark Christopher Schiller
Conseiller Juridique Général chez KEZAR LIFE SCIENCES, INC.
Fortune : - $ au 30/04/2024
Provenance du réseau au premier degré de Mark Christopher Schiller
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 23 | |
| Subsidiary | Pharmaceuticals: Major | 17 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Mark Christopher Schiller via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| CELGENE | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| MYRIAD GENETICS, INC. | Medical Specialties | Corporate Officer/Principal | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
| Stanford University | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of California, Davis | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO Chairman | |
| ACORDA THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
| ALZHEON, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| RAPT THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Human Resources Officer | |
| CLOVIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| BEAM THERAPEUTICS INC. | Biotechnology | Director/Board Member Private Equity Investor | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Graduate Degree | |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Corporate Officer/Principal Founder | |
| The Rockefeller University | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
| ATEA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| New York University | College/University | Doctorate Degree Graduate Degree | |
| University of Michigan | College/University | Masters Business Admin Doctorate Degree | |
| ATRECA, INC. | Biotechnology | Director/Board Member Chairman | |
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
| IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Bristol-Myers Squibb Pharmaceutical Research Institute | Corporate Officer/Principal | ||
| Yale School of Medicine | College/University | Corporate Officer/Principal | |
| DARÉ BIOSCIENCE, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Duke University School of Medicine | College/University | Doctorate Degree | |
| DECIPHERA PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Medicines 360
 Medicines 360 BiotechnologyHealth Technology Medicines360 is a nonprofit pharmaceutical company that is headquartered in San Francisco, CA and has subsidiaries in the United States. Medicines360's mission is to provide equitable access to medicines and devices for women's health. The non-profit company combines the expertise of a commercial pharmaceutical company with the pro-social ambitions of a nonprofit to achieve this goal. The company was founded by Victoria Hale, and Andrea Olariu has been the CEO since 2010. | Biotechnology | Director/Board Member | |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Director/Board Member | |
Sermonix Pharmaceuticals LLC
 Sermonix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Sermonix Pharmaceuticals LLC operates as a pharmaceutical company that focuses on the development and commercialization of late-stage women?s health products. It offers lasofoxifene, a selective estrogen receptor modulator for the treatment of vulvovaginal atrophy, as well as treatment and prevention of post-menopausal osteoporosis. The company was founded in 2014 by David Portman and is headquartered in Columbus, OH. | Pharmaceuticals: Major | Director/Board Member | |
| Harvard T.H. Chan School of Public Health | College/University | Graduate Degree | |
| OBSEVA SA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistiques
Internationale
| Etats-Unis | 43 |
| France | 2 |
| Allemagne | 2 |
| Israël | 2 |
| Suisse | 2 |
Sectorielle
| Health Technology | 30 |
| Consumer Services | 13 |
| Commercial Services | 4 |
| Finance | 2 |
Opérationnelle
| Director/Board Member | 169 |
| Corporate Officer/Principal | 103 |
| Independent Dir/Board Member | 68 |
| Chief Tech/Sci/R&D Officer | 30 |
| Undergraduate Degree | 29 |
Relations les plus connectées
| Insiders | |
|---|---|
| Franklin Berger | 41 |
| Brian Atwood | 39 |
| David Baltimore | 27 |
| Peter Svennilson | 25 |
| Michael Kauffman | 24 |
| Susan Kelley | 22 |
| Jason Robert Dinges | 22 |
| Lewis Coleman | 20 |
| Jean-Pierre Sommadossi | 17 |
| Elizabeth Garner | 15 |
| Richard Kenney | 14 |
| Graham Cooper | 14 |
| Marc Belsky | 11 |
| Noreen Henig | 10 |
| Wayne Gombotz | 9 |
- Bourse
- Insiders
- Mark Christopher Schiller
- Connexions Sociétés